Ting Pau Oei, a Partner at L Capital Partners, leads the firm’s healthcare investments with a focus on biopharmaceutical. See sector focus and contact routes.
Ting Pau Oei, a Partner at L Capital Partners, leads the firm’s healthcare investments with a focus on biopharmaceutical, medical device, diagnostic, and healthcare services companies across early-stage to growth-stage stages. His portfolio includes notable companies such as Protez Pharmaceuticals Inc. (acquired by Novartis in 2008) and Tengion (which went public via IPO). Oei’s distinctive thesis centers on life sciences innovation, having invested in over 50 venture capital deals in emerging biotech and diagnostics firms while serving on the boards of more than 20 venture-backed companies.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Ting Pau Oei · Full investor directory · Investor access · Company funding database